Form 4 for SNTI Senti Biosciences Holdings, Inc.
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0001854270-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | SNTI | Lu Timothy K | CEO, Dir | S - Sale | $4.11 | -4,467 | 82.1K | -5% | -$18.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 3,922 | $4.07 | 82,627 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-06 | S | D | 545 | $4.36 | 82,082 | D | — | — |